CPGJ has established 4 manufacturing lines of 750-litre animal cell culture bioreactors. Two full production tines with two 3000L cell culture bioreactors are being built. They are equipped with the largest and the most advanced dimensional purified apparatus in China, which enable CPGJ to manufacture 2 million lyophilized sterile powder vials and 1 million liquid filling vials per year. Before 2007 CPGJ will further set up another two 200-litre pilot lines and two 5000-litre production lines to meet the increasing demand of the market in 2007.

CPGJ always regards quality control as basis for the company’s development and globalization strategy and as important as life. With the implementation of GMP and ERP systems, CPGJ has accomplished comprehensive quality management in new drugs’ development, animal trials, clinical trials, pilot and production, as well as in sales and post-sales.